Abstract
Granulocyte colony-stimulating factor (G-CSF) drives the production, survival, differentiation, and inflammatory functions of granulocytes. Reactive oxygen species (ROSs) provide a major thrust of the inflammatory response, though excessive ROSs may be deleterious. G-CSF stimulation showed a time- and dose-dependent increase in ROS production, correlating with activation of Lyn and Akt. Inhibition of Lyn, PI3-kinase, and Akt abrogated G-CSF-induced ROS production. This was also blocked by DPI, a specific inhibitor of NADPH oxidase. Following G-CSF stimulation, neutrophils from Lyn-/- mice produced less ROSs than wild-type littermates. G-CSF induced both serine phosphorylation and membrane translocation of p47phox, a subunit of NADPH oxidase. Because patients with a truncated G-CSF receptor have a high risk of developing acute myeloid leukemia (AML), we hypothesized that dysregulation of ROSs contributes to leukemogenesis. Cells expressing the truncated G-CSF receptor produced more ROSs than those with the full-length receptor. G-CSF-induced ROS production was enhanced in bone marrow-derived neutrophils expressing G-CSFRdelta715, a truncated receptor. The antioxidant N-acetyl-L-cysteine diminished G-CSF-induced ROS production and cell proliferation by inhibiting Akt activation. These data suggest that the G-CSF-induced Lyn-PI3K-Akt pathway drives ROS production. One beneficial effect of therapeutic targeting of Lyn-PI3K-kinase-Akt cascade is abrogating ROS production.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acetylcysteine / pharmacology
-
Animals
-
Bone Marrow Cells / cytology
-
Bone Marrow Cells / enzymology
-
Cell Line
-
Cell Proliferation
-
Dose-Response Relationship, Drug
-
Drug Design
-
Enzyme Inhibitors / therapeutic use
-
Granulocyte Colony-Stimulating Factor / deficiency
-
Granulocyte Colony-Stimulating Factor / metabolism
-
Granulocyte Colony-Stimulating Factor / pharmacology*
-
Humans
-
Leukemia, Myeloid, Acute / drug therapy
-
Leukemia, Myeloid, Acute / genetics
-
Leukemia, Myeloid, Acute / metabolism
-
Mice
-
Mice, Knockout
-
NADPH Oxidases
-
Neutrophils / cytology
-
Neutrophils / enzymology*
-
Phosphatidylinositol 3-Kinases / metabolism*
-
Phosphoinositide-3 Kinase Inhibitors
-
Phosphoproteins / metabolism
-
Protein Transport / drug effects
-
Proto-Oncogene Proteins c-akt / antagonists & inhibitors
-
Proto-Oncogene Proteins c-akt / metabolism*
-
Reactive Oxygen Species / metabolism*
-
Receptors, Granulocyte Colony-Stimulating Factor / genetics
-
Receptors, Granulocyte Colony-Stimulating Factor / metabolism
-
Sequence Deletion / genetics
-
Signal Transduction / drug effects
-
Signal Transduction / genetics
-
src-Family Kinases / antagonists & inhibitors
-
src-Family Kinases / deficiency
-
src-Family Kinases / metabolism*
Substances
-
Acetylcysteine
-
Enzyme Inhibitors
-
Granulocyte Colony-Stimulating Factor
-
NADPH Oxidases
-
Phosphatidylinositol 3-Kinases
-
Phosphoinositide-3 Kinase Inhibitors
-
Phosphoproteins
-
Proto-Oncogene Proteins c-akt
-
Reactive Oxygen Species
-
Receptors, Granulocyte Colony-Stimulating Factor
-
src-Family Kinases
-
neutrophil cytosolic factor 1
-
lyn protein-tyrosine kinase